Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesEndocrine, Nutritional and Metabolic Diseases and DisordersDRG 617-amputation-of-lower-limb-for-endocrine-nutritional-and-metabolic-disorders-with-cc
    Ask Trek AI about this page

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    DRG 617 addresses inpatient lower limb amputation procedures in the setting of endocrine, nutritional, and metabolic disorders with a Complication or Comorbidity, encompassing cases such as diabetes-related amputations. It matters for inpatient reimbursement because the Diagnosis-Related Group groups resource use and clinical complexity to determine payment levels under Medicare.

    Customize your policy alerts

    Sign up for drg 617 policy alerts

    Get alerted when payer policies referencing 617 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 617 Overview

    DRG 617 covers inpatient admissions for amputation of the lower limb associated with endocrine, nutritional, and metabolic disorders when a Complication or Comorbidity is present. Typical cases include amputations related to diabetic foot complications, peripheral vascular disease exacerbated by metabolic conditions, and related surgical and perioperative care. This Diagnosis-Related Group is important for Medicare payment because it groups resource use for major surgical procedures complicated by comorbid metabolic conditions, affecting average payment rates and case-mix adjustment. Understanding the clinical scope helps clarify expected resource intensity for reimbursement.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute perioperative optimization trials: studies examining protocols to reduce intra- and perioperative complications for patients undergoing lower limb amputation related to endocrine, nutritional, or metabolic disorders (most often advanced diabetic foot disease and peripheral arterial disease). These trials enroll hospitalized patients scheduled for major lower-extremity amputation and test interventions such as standardized glycemic control pathways, infection-source control bundles, or enhanced hemodynamic monitoring to reduce immediate postop complications and length of stay. Results are highly relevant to surgeons, hospitalists, and payers because improved perioperative management can lower intensive-care utilization, readmission, and overall inpatient costs for this high-risk DRG population.
    • Comparative effectiveness studies of limb-sparing versus primary amputation decision-making and timing: prospective cohort or pragmatic randomized studies that compare outcomes (mortality, subsequent reoperation, functional status, and total cost of care) in patients with severe ischemic or infected foot/leg wounds who are candidates for staged debridement/revascularization attempts versus early definitive amputation. These studies focus on older adults and patients with diabetes, renal disease, or other metabolic comorbidities typical for DRG 617, assessing which strategies yield better survival, mobility, and resource utilization. Evidence from this research informs clinicians and payers about which pathways produce better long-term value and may influence authorization, bundled-payment design, and care pathways for complex limb-threatening disease.
    • Post-discharge outcomes and rehabilitation effectiveness research: longitudinal studies tracking readmissions, wound healing, prosthetic fitting, functional recovery, and total cost across the 90-day to 1-year post-discharge period for patients who had lower-limb amputation related to metabolic disorders. These studies often evaluate different models of transitional care, home health intensity, outpatient wound clinics, and multidisciplinary rehab to determine what reduces rehospitalization and improves independence among patients with diabetes and multimorbidity. Findings guide hospitals and payers in structuring discharge planning, post-acute provider networks, and reimbursement for services that reduce costly readmissions and improve patient-centered outcomes for this DRG group.

    Related Codes

    614-ADRENAL-AND-PITUITARY-PROCEDURES-WITH-CC-MCC

    Adrenal and Pituitary Procedures with CC/MCC: Inpatient Reimbursement Overview

    615-ADRENAL-AND-PITUITARY-PROCEDURES-WITHOUT-CC-MCC

    Adrenal and Pituitary Procedures without CC/MCC: Inpatient Reimbursement Overview

    616-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    618-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

    619-O-R-PROCEDURES-FOR-OBESITY-WITH-MCC

    O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview

    620-O-R-PROCEDURES-FOR-OBESITY-WITH-CC

    O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

    621-O-R-PROCEDURES-FOR-OBESITY-WITHOUT-CC-MCC

    O.R. Procedures for Obesity without CC/MCC: Inpatient Reimbursement Overview

    622-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    623-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    624-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 25

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.